News
January 29, 2026
MedVasc secures SEK 24 Million financing and advances Solutio™ toward FDA clearance
MedVasc AB has successfully completed production and testing activities in accordance with its previously communicated plan. In parallel, the company closed a new financing round at the end of 2025, raising SEK 24 million through subscriptions exclusively from existing shareholders. The strong participation from current owners demonstrates continued confidence…
May 7, 2025
MedVasc Selected to Present at Prestigious MedTech Pitch Day by HGTF 2025
One of Only 10 Startups Chosen from 86 Applicants to Pitch Before Leading Central European MedTech Investors Lund, Sweden, May 6, 2025 – MedVasc was selected to present at MedTech Pitch Day 2025, hosted by High-Tech Gründerfonds (HTGF), Germany’s largest investment fund for early-stage startups. Out of 86 high-potential…
May 7, 2025
MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device
Lund, Sweden – May 6, 2025 – MedVasc AB, a Swedish medical technology company announces the successful closing of a SEK 10 million financing round earlier this year. The funding supports the company’s final product development phase and preparation for regulatory approval in the United States. The primary focus of the…
May 7, 2025
Dr. Michael Åkesson featured on stage at the American Venous Forum, Atlanta
Our founder Dr. Michael Åkesson was invited to present the results from our first-in-man clinical study at the American Venous Forum in Athens in February. We are very happy to see that there is such great interest from the Venous community and we look forward to bringing SolutioTM in to the hands of…
July 1, 2024
SolutioTM featured on stage at the European Venous Forum in Athens
Our founder Dr. Michael Åkesson was invited to present the results from our first-in-man clinical study at the European Venous Forum in Athens last week. We are very happy to see that there is such great interest from the Venous community – we look forward to bringing SolutioTM in to the…
For press inquiries, please send an email
Subscribe to our newsletter
For more information on how we process your personal data please see our Privacy Notice
